CION Cancer Clinics
Treatment choices that change in Li-Fraumeni syndrome | CION Cancer Clinics
A TP53 fault changes a few cancer treatment decisions. Doctors avoid radiation where an equally good option exists, which can shape breast surgery, scans and sometimes chemotherapy. The cancer is still treated fully. This page explains which choices shift, why they shift, how the result reaches your team, and why a TP53 change found only in the tumour does not count. At CION Cancer Clinics, our oncologists plan screening and care for families with an inherited cancer syndrome, explained in plain words.
On this page
- Does a TP53 fault change how cancer is treated?
- Which treatment decisions are most affected?
- How does a TP53 result reach your treatment plan?
- What do the terms your oncologist uses mean?
- What is done differently for a TP53 carrier?
- What this page cannot tell you
- Four things patients tell us, and what is actually true
- Common questions about treatment with a TP53 fault
The short answer
Does a TP53 fault change how cancer is treated?
Yes, in a few specific ways. The main change is that doctors avoid radiation where an equally good option exists, because TP53 carriers are more easily harmed by it. That affects surgery choices for breast cancer, which scans are used, and sometimes which chemotherapy is picked. The cancer in front of you is still treated properly. Nothing effective is withheld because of the gene.
Why radiation matters more here
TP53 is the cell's emergency brake after damage. Radiation damages cells on purpose. In most people, healthy cells in the treated area repair that damage or die off safely. In a carrier, some of those cells can go on to form a new cancer years later, usually in the area that was treated. That risk is weighed against the benefit every time.
Why the timing of the test matters
These choices can only be made if the team knows about the fault before treatment starts. When someone newly diagnosed fits the patterns that suggest Li-Fraumeni syndrome, doctors may ask for the genetic result quickly so it can shape the plan.
A TP53 change found only in the tumour does not change these decisions. That is a different test, covered on our targeted therapy pages.Where the plan shifts
Which treatment decisions are most affected?
Four areas come up again and again when an oncologist plans treatment for someone with a known TP53 fault.
Breast cancer surgery
Removing only the lump usually needs radiotherapy afterwards, so removing the whole breast is often favoured instead. Preventive removal of the other breast may also be discussed as one option among several.
Usually discussed
- Mastectomy rather than lumpectomy
- Reconstruction choices that suit you
- Future risk in the other breast
Radiotherapy
It is still used when it is clearly the best or only way to control a cancer, for example for some brain tumours. The treated area is then watched closely for years afterwards.
Scans for staging and follow-up
MRI and ultrasound are chosen over CT wherever they can answer the question. PET-CT and CT are still used when the answer genuinely depends on them, but not by routine habit.
Chemotherapy choices
Some drugs work by damaging DNA and may add to the chance of a later cancer. Where two regimens work equally well, an oncologist may lean towards the gentler one. The evidence here is limited, and the cancer's needs come first.
Not sure whether this applies to you?
Ask an oncologistBehind the scenes
How does a TP53 result reach your treatment plan?
The fault is identified
Either you already know from family testing, or your history prompts a germline test around the time of diagnosis. The result is added to your hospital record.
Every specialist is told
The surgeon, medical oncologist, radiation oncologist and radiologist all need to know. Carry your report and mention it at every new appointment, even outside your main hospital.
The case is discussed together
A tumour board, where specialists review a case together, weighs the options for your cancer against your long-term risk.
Choices are explained with their trade-offs
You are told what each option offers and what it costs you, in future risk as well as side effects. You make the final decision with your family.
Follow-up joins the surveillance plan
After treatment, check-ups for the first cancer are combined with whole-body surveillance, so you are not scanned twice for the same thing.
In the consultation
What do the terms your oncologist uses mean?
- Breast-conserving surgery
- Removing the lump and a rim of healthy tissue while keeping the breast. It is usually followed by radiotherapy.
- Mastectomy
- Removing the whole breast. For many carriers it avoids the need for radiotherapy to the breast.
- Radiation-induced cancer
- A new cancer that develops in an area treated with radiation, usually years later. Carriers face a higher chance of this.
- DNA-damaging chemotherapy
- Drugs that kill cancer cells by breaking their DNA. Some may slightly raise the chance of a later cancer.
- Tumour board
- A meeting where surgeons, oncologists, radiologists and pathologists plan treatment for one person together.
- Germline result
- A test on blood or saliva showing a fault present from birth. This, not a tumour result, is what changes these choices.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
What is done differently for a TP53 carrier?
Being straight with you
What this page cannot tell you
It cannot tell you what your treatment should be. That depends on the type and stage of your cancer, your age, what you have already had, and what matters most to you. Your oncologist and the tumour board weigh all of that together. Much of the advice in this area comes from small studies and expert agreement rather than large trials, and your team should be open about that.
It cannot interpret your report
What your specific variant means is a question for the counsellor who ordered the test. Some TP53 variants behave more mildly than others, and that can change how strictly radiation is avoided.
Who this does not apply to
These adjustments are for people with a confirmed germline TP53 fault. They do not apply when TP53 appears only on a tumour report, which is very common, or when a report shows only a variant of uncertain significance. Most people treated for cancer do not need them.
If you are unsure whether your TP53 result is germline or tumour-only, ask before treatment decisions are made.Commonly believed
Four things patients tell us, and what is actually true
It is avoided where there is an equally good option, not banned. When radiotherapy is the best way to control a cancer, it is used, and the treated area is watched carefully afterwards.
It is often recommended, because it can avoid radiotherapy. It is still your decision, made after your surgeon has explained every option and its trade-offs.
Some drugs may add a small extra risk, but most carriers who have chemotherapy do not develop a cancer because of it. The benefit against the cancer being treated usually comes first.
Urgent treatment is not delayed. Where a decision could change, such as the type of breast surgery, the team may ask for the result quickly and plan around it.
Questions we are asked
Common questions about treatment with a TP53 fault
Should I tell every doctor that I carry TP53?
Yes. Tell every doctor, dentist and scan centre, including for problems that have nothing to do with cancer. A routine X-ray or CT for a minor complaint may have a radiation-free alternative. Keep a copy of your report or clinic letter on your phone.
Can I still have a dental X-ray?
Small dental X-rays give a very low dose and are usually acceptable when they are genuinely needed. Tell your dentist about the fault so that X-rays are taken only when they will change what is done, not as a routine every visit.
Does the fault change which cancer medicines work?
Not in the way BRCA faults do. There is no medicine approved specifically because someone carries a germline TP53 fault. Research is ongoing. Treatment is chosen for the cancer itself, with the future-risk considerations explained on this page.
What if I already had radiotherapy before we knew?
That is common and it was the right call with the information available. Tell your team, because the treated area may then be watched more closely as part of your surveillance plan. It does not mean a new cancer is expected there.
Is PET-CT safe for staging?
It does involve radiation. It is still used when it gives an answer nothing else can, for example to find spread before major surgery. Your team will use it when it truly changes the plan rather than for routine follow-up.
Should I consider preventive surgery on the other breast?
It is one option to discuss, alongside yearly breast MRI. Some women choose it and others do not. Our pages on risk-reducing surgery explain the choice in detail, and your surgeon can talk it through before or after your cancer treatment.
Does a child with Li-Fraumeni syndrome get different treatment?
The same principles apply. The paediatric team avoids radiation where an equally good option exists and plans the long-term follow-up carefully. Children's cancers are treated with their usual intensity, because controlling the cancer now matters most.
Who should I talk to about my treatment choices?
Your medical oncologist, with input from the surgeon and radiation oncologist, and a genetic counsellor for the family side. Bring your TP53 report to every visit. Call the CION helpline if you would like a second opinion on a treatment plan.
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- GeneReviews (NCBI) — Li-Fraumeni Syndrome
- MedlinePlus Genetics — Li-Fraumeni syndrome
- MedlinePlus Genetics — TP53 gene
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Want a second look at a treatment plan?
If you carry a TP53 fault and are facing treatment, tell us what has been proposed. We will arrange for an oncologist to go through the options with you and your family. One helpline serves every CION centre.